Icosavax Inc (ICVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2017 | 12-2006 | |
| Sales | 582 | 7,802 | 1,616 | 0 | 0 |
| Gross Profit | 582 | 7,802 | 1,616 | N/A | N/A |
| Operating Expenses | 95,640 | 73,663 | 20,326 | 0 | 0 |
| Operating Income | -95,058 | -65,861 | -18,710 | N/A | N/A |
| Other Income | 3,300 | -1,110 | -144 | 0 | 0 |
| Pre-tax Income | -91,758 | -66,971 | -18,854 | 0 | 0 |
| Net Income Continuous | -91,758 | -66,971 | -18,854 | N/A | N/A |
| Net Income | $-91,758 | $-66,971 | $-18,854 | $N/A | $N/A |
| EPS Basic Total Ops | -2.31 | -3.73 | -8.40 | N/A | N/A |
| EPS Basic Continuous Ops | -2.31 | -3.73 | -8.40 | N/A | N/A |
| EPS Diluted Total Ops | -2.31 | -3.73 | -8.40 | N/A | N/A |
| EPS Diluted Continuous Ops | -2.31 | -3.73 | -8.40 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -2.31 | -3.73 | N/A | N/A | N/A |
| EBITDA(a) | $-95,726 | $-65,779 | $-18,709 | $N/A | $N/A |